Financhill
Sell
14

ESPR Quote, Financials, Valuation and Earnings

Last price:
$1.70
Seasonality move :
3.95%
Day range:
$1.60 - $1.72
52-week range:
$1.47 - $3.94
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.98x
P/B ratio:
--
Volume:
5M
Avg. volume:
3.7M
1-year change:
-19.91%
Market cap:
$334.4M
Revenue:
$332.3M
EPS (TTM):
-$0.25

Earnings Data

Next earnings date for ESPR
May 07
2025
Most recent earnings per share
-$0.11
Beat by $0.05
(Mar 4/2025)
Consensus Estimate
-$0.16
(Mar 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ESPR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/07/2025 Q1 $55M -- -- -$0.19 --
03/04/2025 Q4 $61.6M $69.1M -$0.11 -$0.16 $0.05
11/07/2024 Q3 $51.7M $51.6M -$0.15 -$0.17 $0.02
08/12/2024 Q2 $47.5M $73.8M -$0.33 -$0.17 -$0.16
05/07/2024 Q1 $83.9M $137.7M $0.34 -$0.01 $0.35
02/27/2024 Q4 $28.7M $32.3M -$0.50 -$0.48 -$0.02
11/07/2023 Q3 -- -- -$0.37 -$0.42 $0.05
08/01/2023 Q2 -- -- -$0.46 -$0.63 $0.17
05/09/2023 Q1 -- -- -$0.79 -$0.66 -$0.13
02/21/2023 Q4 -- -- -$0.76 -$0.85 $0.09
11/01/2022 Q3 -- -- -$0.81 -$0.93 $0.12
08/02/2022 Q2 -- -- -$1.05 -$0.92 -$0.13
05/03/2022 Q1 -- -- -$0.93 -$1.04 $0.11
02/22/2022 Q4 -- -- -$1.77 -$2.29 $0.52
11/02/2021 Q3 -- -- -$2.62 -$2.80 $0.18
08/03/2021 Q2 -- -- -$1.67 -$1.85 $0.18
05/04/2021 Q1 -- -- -$3.50 -$2.72 -$0.78
02/23/2021 Q4 -- -- -$3.89 -$3.99 $0.10
11/02/2020 Q3 -- -- -$3.07 -$3.57 $0.50
08/10/2020 Q2 -- -- $4.32 $1.40 $2.92
05/06/2020 Q1 -- -- -$2.84 -$3.24 $0.40
02/27/2020 Q4 -- -- -$2.26 -$2.67 $0.41
11/06/2019 Q3 -- -- -$2.52 -$1.92 -$0.60
08/08/2019 Q2 -- -- -$2.01 -$1.82 -$0.19
05/08/2019 Q1 -- -- $3.07 $0.86 $2.21
02/28/2019 Q4 -- -- -$2.24 -$1.12 -$1.12
11/01/2018 Q3 -- -- -$1.86 -$1.64 -$0.22
08/02/2018 Q2 -- -- -$1.71 -$1.72 $0.01
05/02/2018 Q1 -- -- -$1.73 -$1.59 -$0.14
02/20/2018 Q4 -- -- -$1.44 -$1.77 $0.33
11/07/2017 Q3 -- -- -$1.86 -$1.77 -$0.09
08/08/2017 Q2 -- -- -$1.92 -$1.62 -$0.30
05/04/2017 Q1 -- -- -$1.80 -$1.46 -$0.34
02/22/2017 Q4 -- -- -- -- --
11/03/2016 Q3 -- -- -- -- --
08/04/2016 Q2 -- -- -- -- --
05/05/2016 Q1 -- -- -- -- --
03/03/2016 Q4 -- -- -- -- --
11/09/2015 Q3 -- -- -- -- --
08/06/2015 Q2 -- -- -- -- --
05/07/2015 Q1 -- -- -- -- --

Esperion Therapeutics Earnings Questions

  • How Much did Esperion Therapeutics Generate in Revenue Last Quarter?

    Esperion Therapeutics reported $69.1M worth of top line sales in its most recent quarter.

  • Did Esperion Therapeutics Beat Earnings Last Quarter?

    Esperion Therapeutics announced earnings per share of -$0.11 which represents a beat of analyst forecast a -$0.16 per share.

  • Is Esperion Therapeutics Profitable?

    Esperion Therapeutics reported $43.5M that represents $0.22 per share over the last quarter.

  • What is the Analyst Consensus for Esperion Therapeutics EPS Next Year?

    Esperion Therapeutics's earnings are forecast to decrease from -$0.28 per share to -$0.33 per share next year representing a decrease of -88.1%.

  • When is Esperion Therapeutics's Earnings Date?

    Esperion Therapeutics's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock